CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
REVENUES:
Operating revenues - equipment sales and related services	$ 1,125,249	$ 1,242,264
Operating revenues - cryobanking and related services	321,096	336,993
Total Revenues	1,446,345	1,579,257
Costs of sales-equipment sales and related services	616,063	691,786
Costs of sales-cryobanking and related services	36,448	35,864
Total Costs of Sales	652,511	727,650
Gross Profit	793,834	851,607
OPERATING EXPENSES:
Research and development-equipment sales and related services	2,508,657	2,826,068
Research and development-cryobanking and related services	197,295	215,572
Total Research and Development Expenses	2,705,952	3,041,640
Selling, general, and administrative- equipment sales and related services	3,219,204	2,750,626
Selling, general and administrative- cryobanking and related services	655,092	718,452
Total Selling, General and Administrative Expenses	3,874,296	3,469,078
Total Operating Expenses	6,580,248	6,510,718
Loss from Operations	(5,786,414)	(5,659,111)
Dividend income-investment portfolio	2,237,734	2,226,198
Realized gains on sale of securities, net	33,189	13,509,318
Mark to market of short positions	(8,501,859)	(1,526,064)
Other revenues	12,374	12,166
Interest expense, net of interest income of $6,425 and $1,944	(168,923)	(61,676)
Administrative expenses relating to portfolio investments	(153,816)	(150,675)
Total Other (expense) income, net	(6,541,301)	14,009,267
(Loss) Income before income taxes	(12,327,715)	8,350,156
(Benefit ) provision for income taxes	(5,142,076)	3,381,892
Net (Loss) Income	(7,185,639)	4,968,264
Weighted average number of shares outstanding – basic and diluted	$ 4,219,654	$ 4,237,216
Net (loss) income per common equivalent share –basic and diluted (in Dollars per share)	$ (1.70)	$ 1.17
Dividends paid per common share (in Dollars per share)	$ 0.25	$ 1.00